Annual Gross Margin
68.23%
+7.20%+11.80%
December 31, 2023
Summary
- As of March 12, 2025, RVNC annual gross profit margin is 68.23%, with the most recent change of +7.20% (+11.80%) on December 31, 2023.
- During the last 3 years, RVNC annual gross margin has fallen by -0.65% (-0.94%).
Performance
RVNC Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Gross Margin
70.55%
-2.48%-3.40%
September 30, 2024
Summary
- As of March 12, 2025, RVNC quarterly gross profit margin is 70.55%, with the most recent change of -2.48% (-3.40%) on September 30, 2024.
- Over the past year, RVNC quarterly gross margin has stayed the same.
Performance
RVNC Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
RVNC Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.8% | 0.0% |
| 3 y3 years | -0.9% | +0.5% |
| 5 y5 years | - | - |
RVNC Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.4% | -10.6% | -3.4% | -25.0% |
| 5 y | 5-year | -2.4% | -10.6% | -24.1% | -25.0% |
| alltime | all time | -31.2% | -10.6% | -24.1% | -25.0% |
Revance Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 70.55%(-3.4%) |
| Jun 2024 | - | 73.03%(+2.4%) |
| Mar 2024 | - | 71.29%(+8.7%) |
| Dec 2023 | 68.23%(+11.8%) | 65.58%(-4.8%) |
| Sep 2023 | - | 68.91%(+1.9%) |
| Jun 2023 | - | 67.64%(-7.0%) |
| Mar 2023 | - | 72.72%(+37.5%) |
| Dec 2022 | 61.03% | 52.90%(-16.0%) |
| Sep 2022 | - | 63.00%(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | 66.43%(-3.4%) |
| Mar 2022 | - | 68.75%(-1.3%) |
| Dec 2021 | 69.91%(+1.5%) | 69.63%(-0.8%) |
| Sep 2021 | - | 70.19%(-1.3%) |
| Jun 2021 | - | 71.14%(+4.2%) |
| Mar 2021 | - | 68.29%(+1.8%) |
| Dec 2020 | 68.88%(-30.5%) | 67.10%(-6.4%) |
| Sep 2020 | - | 71.71%(-22.9%) |
| Jun 2020 | - | 92.98% |
| Dec 2011 | 99.10% | - |
FAQ
- What is Revance Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Revance Therapeutics?
- What is Revance Therapeutics annual gross margin year-on-year change?
- What is Revance Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Revance Therapeutics?
- What is Revance Therapeutics quarterly gross margin year-on-year change?
What is Revance Therapeutics annual gross profit margin?
The current annual gross margin of RVNC is 68.23%
What is the all time high annual gross margin for Revance Therapeutics?
Revance Therapeutics all-time high annual gross profit margin is 99.10%
What is Revance Therapeutics annual gross margin year-on-year change?
Over the past year, RVNC annual gross profit margin has changed by +7.20% (+11.80%)
What is Revance Therapeutics quarterly gross profit margin?
The current quarterly gross margin of RVNC is 70.55%
What is the all time high quarterly gross margin for Revance Therapeutics?
Revance Therapeutics all-time high quarterly gross profit margin is 92.98%
What is Revance Therapeutics quarterly gross margin year-on-year change?
Over the past year, RVNC quarterly gross profit margin has changed by 0.00% (0.00%)